Trade Mark Journal No.2026/033 14 August 2026

WO0000001930460 (5)

Office of origin: United States of America

Date of International Registration:8 April 2026
Date of designation in the UK: 8 April 2026
Image for mark 1930460 DAMORA THERAPEUTICS

International priority date claimed: 23 October 2025 (United States of America) (99458830)
Class 5
Antibodies for therapeutic purposes; pharmaceutical preparations for the treatment of cancer, myeloproliferative disorders, and hematological disorders.

Damora Therapeutics, Inc.

Representative: Nicole Kinsley FOLEY HOAG LLP, 155 Seaport Blvd., Boston MA 02210, UNITED STATES OF AMERICA